Наталия Дзеружинская - Психические и поведенческие расстройства при ВИЧ-инфекции и СПИДе: учебное пособие
Фрустрация – психическое состояние, возникающее в случае неудовлетворения актуальной потребности и сопровождающееся отрицательными эмоциональными переживаниями: разочарованием, раздражением, тревогой, отчаянием и др.
Рекомендованная литература
1. Бородкина О.Д. Пограничные нервно-психические расстройства у больных с ВИЧ-инфекцией на латентной стадии заболевания: Типология, динамика, реабилитация: Автореф. дисс.... докт. мед. наук. Кемерово, 2005. – 23 с.
2. ВIЛ-iнфекцiя в Украiнi/Iнформацiйний бюлетень, № 37. – Киiв, 2012. – 82 с.
3. Гавенко В.Л., Битенский B.C. Психиатрия и наркология: Учебник Медицина, 2009. – С.199-204.
4. Жабенко Н.Ю. Психiчнi розлади у хворих iнфкованих ВИЛ (клiнiка, дiагностика, психокорекцiя) Автореф. дисс…канд. медичних наук. – Харькiв.: АМНУ, 2012. – 20 с.
5. Лобанов СО. Психотерапiя та реабiлiтацiя хворих з опiоiдною наркоманiею обтяженою ВIЛ (СНIД). Автореф. Дисс… канд.. медичних наук. – К.: УНДI ССПН, 2012. – 19 с.
6. Незнанов Н.Г., Халезова Н.Б. Распространенность и характер психических расстройств у ВИЧ-инфицированных больных С.-Петербурга // Психические расстройства в общей медицине. 2007. Т. 2, № 2.
7. Офiцiйний сайт Всесвiтньоi органiзацii охорони здоров’я [Электронный ресурс]: http://www.who.int.
8. Покровский В.В., Юрин О.Г., Беляева В.В. и соавт. Клиническая диагностика и лечение ВИЧ-инфекции: Практическое руководство для врачей-интернов, студентов, клинических ординаторов и врачей всех специальностей. М.: ГОУ ВУНМЦ МЗ РФ, 2001. – С. 26-31.
9. Полянский ДА, Калинин В.В. Проблема психических расстройств у ВИЧ-инфицированных больных. 2010_12_scp_193.pdf
10. Сервецький А.К. Клiнiко-психопатогiчна характеристика адаптацiйних розладiв ВIЛ-iнфiкованих пацiентiв. Автореф. Дисс....кандитата медичних наук. – К.: УНДI ССПН, 2008. – 16 с.
11. Филиппова О.В. Когнiтивнi та афективнi розлади у пацiентiв з опiоiдною залежнiстю, обтяженою ВIЛ-iнфiкцiею (дiагностика, клiнiка, лiкування) Автореф. Дисс…канд.. медичних наук. – К.: УНДI ССПН, 2012. – 20 с.
12. Adler M.W. ABC of AIDS. Development of the epidemic // Br. Med. J. – 1987. – Vol. 294. – P. 1083-1085.
13. American Psychiatric Association. AIDS policy: guidelines for inpatient psychiatric units. Am J Psychiatry 1992; 149: 722.
14. Anderson M. Virus infections of the nervous system // Brain’s Diseases of the Nervous System, 10th edn, ch.9. Oxford: Oxford University Press, 1993.
15. Angelini L., Zibordi F., Triulzi F. et al. Age-dependent neurologic manifestations of HIV infection in childhood // Neurol. Sci. – 2000. – Vol. 21. – P. 135–142.
16. Asare E.K., Glass J.D., Luthert P.J. et al. Neuronal pattern diferences in HIV-associated dementia // Neuropathol. Applied Neurobiol. – 1995. – Vol. 151. – P. 21.
17. Atkinson J.H., Heaton K.K., Patterson T.L. et al. Two-year prospective study of major depressive disorder in HIV-infected men // J. Afect. Dis. – 2008. – Vol. 108. – P. 225–234.
18. Ayd FS Jr, Janicak PG, Davis JM. Advances in pharmacotherapy of psychotic disorders II. The novel antipsychotics. In: Janicak PG, ed. Principles and practice of pychopharmacotherapy. Update Vol. 1, No. 5. Baltimore: Williams & Wilkins. 1997.
19. Baingana F, Thomas R and Comblain C (2005) HIV/AIDS and mental health. Health, Nutrition and Population discussion paper, World Bank. Free download from www.worldbank.org
20. Batki SL. Busiprone in drug users with AIDS or AIDS related complex. J Clin Psvchopharmacol 1990; 10(Suppl 3): 1115-1155.
21. Batki SL. Drug abuse, psychoactive disorders and AIDS: dual and triple diagnosis. West J Med 1990; 152: 547-552.
22. Becker J.T., Lopez O.L., Dew M.A., Aizenstein H.J. Prevalence of cognitive disorders as a function of age in HIV virus function // AIDS. – 2004. – Vol. 18, Suppl.1. – P. 511–518.
23. Bell J.E., Brettle R.P., Chiswick A., Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexual with AIDS. Efect on neocortical involvement // Brain. – 1998. – Vol. 121. – P. 2043–2052.
24. Bell J.E., Bussuttil A., Ironside J.W. et al. Human immuno-defciency virus and the brain: investigation of virus load and neuro-pathologic changes in pre-AIDS subjects // J. Infectious Diseases. – 1993. – Vol. 168. – P. 818–824.
25. Binder RL. AIDS antibody tests on inpatient psychiatric units. Am J Psychiatry 1987; 144:176-181.
26. Brew B.J. HIV Neurology. Oxford University Press, 2001. – P. 64–90.
27. Brew B.J., Pemberton L., Cunningham P. et al. Levels of HIV-1 RNA correlate with AIDS dementia // J. Infection Dis. – 1997. – Vol. 175. – P. 963–966.
28. Budka H. Neuropathology of human immunodefciency virus infection // Brain Pathology. – 1991. – Vol. 1. – P. 163–175.
29. Burch EA, Montoya J. NMS in an AIDS patient. J Clin Psychiatry 1989; 9: 228-229.
30. Carrico A.W., Johnson M.O., Morin S.F. et al. Correlates of suicidal ideation among HIV-positive persons // AIDS. – 2007. – Vol. 21. – P. 1199–1203.
31. Catalan J, Burgess A, Klimes I (1995). Psychological medicine of HIV infection. Oxford University Press, Oxford, UK.
32. Centre for Harm Reduction (2003). Manual for reducing drug-related harm in Asia. Melbourne, Australia. EuroHIV (2005).
33. Chang L., Ernst T., Leonido-Yee M. et al. Cerebral metabolites correlate with clinical severity of HIV-cognitive motor complex // Neurology. – 1999. – Vol. 52. – P. 100–108.
34. Childs E.A., Lyler R.H., Selnes O.A. et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy // Neurology. – 1999. – Vol. 52. – P. 607–613.
35. Cournos F, Empfeld M, Horwath E, Kramer M. The management of HIV infection in state psychiatric hospitals. Hosp Comm Psychiatry 1989; 40: 153-158.
36. Cummings J.L., Benson D.F. Dementia: A Clinical Approach, 2nd edition. London: Butterworths, 1992.
37. Davis JM, Janicak PG, Preskorn SH, Ayd F Jr. Advances in the psychopharmacotherapy of psychotic disorders. In: Janicak PG, ed. Principles and practice of psychopharmacotherapy. Update Vol. 1, No 1. Baltimore: Williams & Wilkins, 1994.
38. De Ronchi D., Faranca I., Forti P. et al. Development of acute psychotic disorders and HIV-1 infection // Int. J. Psychiatry Med. – 2000. – Vol. 30. – P. 173–183.
39. DiClemente RJ, Ponton LE. HIV-related risk behaviors among psychiatrically hospitalized adolescents and school-based adolescents. South J Psychiatry 1993; 150: 324-325.
40. Dunbar N., Brew B.J. Neuropsychological dysfunction in HIV infection: a review // J. NeuroAIDS. – 1996. – Vol. 1, № 3. – P. 73–102.
41. Einsiedel R.W. von, Berger T., Weisbrod M. et al. HIV-Patienten mit psychiatrischen Krankheiten. Behandlungsstrategien und Medikamenteninteraktionen // Nervenarzt. – 2001. – Vol. 72. – P. 204–215.
42. Feinberg T.E., Farah M.J. Behavioral neurology and neuropsychology. 2nd edition. Part 7. 2003. – Ch. 50. – P. 629–637.
43. Fernandez F, Adams F, Levy JK, et al. Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 1988; 29: 38-46.
44. Fernandez F. Neuropsychiatric aspects of human immunodefciency virus (HIV) infection // Curr. Psychiatry Reports. – 2002. – Vol. 4. – P. 228–231.
45. Foster R., Olajide D., Everall I.P. Antiretroviral therapy-induced psychosis: case report and brief review of the literature // HIV Medicine. –2003. – Vol. 4. – P. 139–144.
46. Foster R., Taylor C., Everall I.P. More on abacavir-induced neuropsychiatric reactions // AIDS. – 2004. –Vol. 18. – P. 24–49.
47. Gilmer W, Busch K. Neuropsychiatric aspects of AIDS and psychopharmacologic management. Psychiatr Med 1991; 9: 313-329.
48. Haller D.L., Miles D.R. Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of live // AIDS Behav. –2003. –Vol. 7. – P. 101–108.
49. Halman MH,Worth JL, Sanders KM, et al. Anticonvulsant use in the treatment of manic syndrome in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 1993; 5: 430-434.
50. Hamers F. and Downs A. HIV in central and eastern Europe. The Lancet. – 2003. – Vol. 361. – Р. 1035-44, 22March.
51. Horwath E, Kramer M, Cournos F, et al. Clinical presentations of AIDS and HIV infection in state psychiatric facilities. Hosp Comm Psychiatry 1989; 40: 502-514.
52. Jacobsberg LB, Perry S. Medical management of AIDS patients: psychiatric disturbances. Med Clin North Am 1992; 76: 99-106.
53. Janicak PG. Psychopharmacotherapy in the HIV-infected patient. Psychiatric Ann 1995; 25 (10): 609-613.
54. Jobe ТН. Neuropsychiatry of HIV disease. In: Flaherty J, Davis JM, Janicak PG, eds. Psychiatry: diagnosis and therapy. New York: Appleton and Lange, 1993.
55. Justice A.C., McGinnis K.A., Atkinson J.H. et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study // AIDS. – 2004. – Vol. 18, Suppl.1. – P. 49–59.
56. Kalichman S (1995). Understanding AIDS: A guide for mental health professionals. American Psychological Association. Washington DC, USA.
57. Kalichman S.C., Heckman T., Kochman A., Sikkema K., Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS // Psychiatr. Serv. – 2000. – Vol. 51. – P. 903–907.
58. Kalichman SC, KellkyJA, Johnson J, et al. Factors associated with risk for human immunodefciency versus (HIV) infection among chronically mentally ill adults. Am J Psychiatry 1993; 151:121-127.
59. King M.B. AIDS, HIV and Mental Health. Cambridge: Cambridge niversity Press, 1993.
60. King M.B. Psychological status of 192 out-patients with HIV infection and AIDS // Br. J. Psychiatry. – 1989. – Vol. 154. – P. 237–242.
61. Lishman’s organic psychiatry: a textbook of neuropsychiatry /A. David et al. (Eds.). 4th Edition. Part 2. – 2009. – Ch. 7. – P. 397–472.
62. Low-Beer S., Clan K., Hogg R.S. et al. Depressive symptoms decline among persons on HIV protease inhibitors // J. Acquired Immune Defc. Syndrome. – 2000. – Vol. 23. – P. 295–301.
63. Lyketsos C.G., Hanson A.L., Fishman M. et al. Screening for psychiatric disorders in an HIV medical clinic: the importance of a psychiatric presence // Int. J. Psychiatry. Med. – 1994. – P. 103– 113.
64. Maj M, Janssen R, Starace F, et al. WHO neuropsychiatry AIDS study, cross-sectional phase 1. Arch Gen Psychiatry 1994; 51: 39-49.
65. Marzuk P.M. Suicidal behavior and HIV illness // Int. Rev. Psychiatry. 1991. – Vol. 3. – P. 365–371.
66. Marzuk P.M., Tierney H., Tardif K. et al. Increased risk of suicide in persons with AIDS // J. Am. Med. Association. – 1988. – Vol. 259. – P. 1333–1337.
67. Maschke M., Kastrup O., Esser S. et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) // J. Neurology, Neurosurgery and Psychiatry. – 2000. – Vol. 69. – P. 376–380.
68. Menza MA, Murray GB, Holmes VF, et al. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280.
69. Navia B.A., Lee P.L., Chang L. et al. Metabolite changes in the basal ganglia provide a signature for the AIDS dementia complex: a multicenter proton magnetic resonance study // Neurology. – 1999. – Vol. 52. – P. (S2): A253.
70. Ofah C.E., Turnbull I.W. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients // Clin. Radiol. – 2006. – Vol. 61. – P. 393–401.
71. Ostrow D, Grant I, Atkinson H. Assessment and management of AIDS patients with neuropsy-chiatric disturbances. J Clin Psychiatry 1988; 49 (Suppl): 14-22.
72. Patrick D., Tyndall M., Cornelisse P. et al. Incidence of hepatitis C virus among drug users duringan outbreak of HIV infection. // Canadian Medical Association Journal. – 2001. – Vol. 165. – Р. 889–895.
73. Pence B.W., Miller W.C., Whetten K. et al. Mental disorders common among HIV-infected patients // J. Acquired Immune Defcit Syndrome. – 2006. – Vol. 42. – P. 298–306.
74. Perkins D.O., Stern R.A., Golden R.N. et al. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic // Am. J. Psychiatry. – 1994. – Vol. 151. – P. 223–236.
75. Preskorn S, Janicak PG, Davis JM, Ayd F Jr. Advances in the psychopharmacotherapy of depressive disorders. In: Janicak PG, ed.
76. Principles and practice of psychopharmacotherapy. Update, Vol 1 (3). Baltimore: Williams & Wilkins, 1995.
77. Regier D., Farmer M., Rae D. et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. – 1990. – Vol. 26 (19). – Р. 2511-2518.
78. REPSSI (2004). About REPSSI: State of the initiative, 2003. Regional Psychosocial Support Initiative. http://www.repssi.org/ initiativestate.htm
79. Sejvar J.J. The evolving epidemiology of viral encephalitis // Curr. Opinion Neurol. – 2006. – Vol. 19. – P. 350–357.
80. Sewell D. Schizophrenia and HIV // Schizophr. Bull. – 1996. – Vol. 22. – P. 465–473.
81. Shader R.I., Kennedy J.S. Biological treatments / H.I.Kaplan, B.J.Sadock (Eds.). Comprehensive Textbook of Psychiatry. Baltimore: Williams and Wilkins, 1989. – Vol. 2. – P. 2037–2049.
82. Singh A, Catalan J: Risperidone in HIV-related manic psvchosis [Letter], Lancet 1994; 344:1029-1030.
83. Sitdis J.J. et al. Стадии СПИД-дементного комплекса, 1990.
84. Thomas C.S., Szabadi E. Paranoid psychosis as the frst presentation of a fulminating lethal case of AIDS // Br. J. Psychiatry. – 1987. – Vol. 151. – P. 693–695.
85. Treisman G.J., Angelino A.F., Hutton H.E. Psychiatric issues in the management of patients with HIV infection // J. Am. Med. Association. – 2001. – Vol. 286. – P. 2857–2864.
